Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty acid biosynthesis enzymes are a group of proteins responsible for the de novo synthesis of fatty acids from acetyl-CoA and NADPH. This process is essential for producing key cellular components such as membrane lipids, energy storage molecules (like triacylglycerides), and precursors for various metabolites. The pathway is highly conserved across all domains of life, but the organization and regulation of the enzymes differ between organisms. Key enzymes include Acetyl-CoA Carboxylase (ACC), Fatty Acid Synthase (FAS), Acyl Carrier Protein (ACP), Desaturases, and Elongases. Regulation occurs via allosteric effectors and covalent modification. Inhibitors targeting bacterial Type II FAS are promising antibiotics. Dysregulation in humans can contribute to metabolic diseases like obesity, diabetes, cancer.
Inhibition of fatty acid synthesis
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty Acid Biosynthesis Enzymes (FAS Enzymes).